Science Explorer Back to mapMap
Discussion
Researcher · Research Triangle Park Foundation · United States

Ranjani Manjunath

Ranjani Manjunath publishes mostly in Psychiatry and Mental health, Economics and Econometrics and Pediatrics, Perinatology and Child Health, on topics such as Epilepsy research and treatment, Pharmacological Effects and Toxicity Studies and Health Systems, Economic Evaluations, Quality of Life.

OpenAlex
World rank
#676,447
of 7,710,434 ranked researchers
Rank in United States
#229,441
of 1,627,098
Works
28
Citations
2.6k
Citations per work
94.3
h-index
18
i10-index 20Top 31% in Psychiatry and Mental health
Ranjani Manjunath

What does Ranjani Manjunath research?

Ranjani Manjunath's work is mostly in Medicine (53%), Economics, Econometrics and Finance (17%).

Health Sciences: 15 works · 52.6% of their workMedicine: 15 works · 52.6% of their workPsychiatry and Mental health: 6 works · 21.3% of their workPediatrics, Perinatology and Child Health: 5 works · 17.5% of their workOncology: 1 works · 5.0% of their workPhysiology: 1 works · 5.0% of their workNeurology: 1 works · 3.8% of their workEverything else: 8 works · 29.9% of their workSocial Sciences: 5 works · 17.5% of their workEconomics, Econometrics and Finance: 5 works · 17.5% of their workEconomics and Econometrics: 5 works · 17.5% of their workTHEIR WORKRanjani Manjunath28works
Health Sciences53%Social Sciences17%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1552.6%
  2. Everything else829.9%
    1. Economics, Econometrics and Finance517.5%
  1. 1Psychiatry and Mental health21% of their works
  2. 2Economics and Econometrics18% of their works
  3. 3Pediatrics, Perinatology and Child Health18% of their works
  4. 4Physiology5% of their works
  5. 5Oncology5% of their works
  6. 6Neurology4% of their works

Research topics

Which keywords describe Ranjani Manjunath's research?

The keywords of their largest research topics: Antiepileptic Drugs, Genetics, Inflammation, Neurobiology, Cognitive Function, Epilepsy, Seizures and Prenatal Exposure.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Antiepileptic Drugs222 topics
  2. Genetics193 topics
  3. Inflammation193 topics
  4. Neurobiology152 topics
  5. Cognitive Function132 topics
  6. Epilepsy121 topic
  7. Seizures121 topic
  8. Prenatal Exposure101 topic
  9. Teratogenicity101 topic
  10. Cost-effectiveness Analysis71 topic
  11. Quality of Life71 topic
  12. Allergic Diseases41 topic
  13. Asthma41 topic
  14. Drug Development Costs41 topic
  15. Generic Drugs41 topic
  16. Off-Label Drug Use41 topic
  17. Pediatric Pharmacokinetics41 topic
  18. Bipolar Spectrum Disorder31 topic
  19. Prevalence31 topic
  20. Child Care21 topic
  21. Infection Control Measures21 topic

Where does Ranjani Manjunath work?

Ranjani Manjunath's main affiliation in the publication record is Research Triangle Park Foundation, United States.

How many publications and citations does Ranjani Manjunath have?

OpenAlex counts 28 works and 2,639 citations for Ranjani Manjunath, an h-index of 18, ranking #676,447 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Ranjani Manjunath. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.